analyst
AO
NYSE · AORT
Artivion, Inc.
Healthcare · Medical - Devices
$25.08
Up+$0.43 (+1.74%)
Updated Sep 14, 2026, 6:11 AM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.84B
- P/E ratio
- 187.45
- Dividend yield
- 0.00%
- 52-week range
- $19.16 – $39.66
- Volume
- 547.89K
- Avg. volume
- 384.16K
Price performance
AORT price history
1M range · 19 trading sessions · Daily adjusted prices
AORT closed at $25.08 after 19 trading sessions, down 11.44% for the selected period.
- Last close
- $25.08
- Period change
- -11.44%
- Period low
- $24.65
- Period high
- $28.90
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $24.96 | $25.28 | $24.40 | $25.08 | 547.89K |
| Sep 10, 2026 | $25.12 | $25.40 | $24.5038 | $24.65 | 694.54K |
| Sep 9, 2026 | $25.15 | $25.72 | $24.72 | $25.22 | 553.8K |
| Sep 8, 2026 | $25.42 | $25.81 | $24.915 | $25.13 | 619.37K |
| Sep 4, 2026 | $25.37 | $25.69 | $25.18 | $25.57 | 418.34K |
| Sep 3, 2026 | $26.50 | $26.90 | $25.45 | $25.62 | 438.79K |
| Sep 2, 2026 | $26.93 | $27.92 | $26.29 | $26.34 | 549.49K |
| Sep 1, 2026 | $27.05 | $27.95 | $26.915 | $27.09 | 675.1K |
| Aug 31, 2026 | $26.46 | $27.10 | $25.86 | $26.99 | 669.07K |
| Aug 28, 2026 | $26.71 | $27.11 | $26.685 | $26.77 | 466.5K |
| Aug 27, 2026 | $26.92 | $27.34 | $26.58 | $26.67 | 440.84K |
| Aug 26, 2026 | $26.18 | $27.42 | $26.02 | $27.20 | 609.02K |
| Aug 25, 2026 | $26.89 | $27.145 | $26.19 | $26.38 | 735.68K |
| Aug 24, 2026 | $28.01 | $28.165 | $26.77 | $26.89 | 1.04M |
| Aug 21, 2026 | $27.86 | $28.605 | $27.82 | $28.08 | 485.22K |
| Aug 20, 2026 | $28.49 | $29.01 | $27.77 | $27.98 | 819.36K |
| Aug 19, 2026 | $29.33 | $30.14 | $28.80 | $28.82 | 679.12K |
| Aug 18, 2026 | $28.80 | $29.98 | $28.62 | $28.90 | 846.92K |
| Aug 17, 2026 | $28.73 | $29.065 | $28.285 | $28.32 | 496.15K |
Latest AORT news
The latest Smart Investors Daily articles mentioning AORT.
Stock researchCompany · Financials
Loading stock research…